4//SEC Filing
CELL THERAPEUTICS INC 4
Accession 0000891293-07-000005
CIK 0000891293operating
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 9:39 PM ET
Size
5.9 KB
Accession
0000891293-07-000005
Insider Transaction Report
Form 4
STROMATT SCOTT
EVP, Clinical Dev & Reg Affair
Transactions
- Award
Incentive Stock Option (right to buy)
2007-01-18+60,000→ 60,000 totalExercise: $1.70Exp: 2017-01-18→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The reporting of this transaction is late due to an administrative oversight.
- [F2]This option vests as follows: 25% shall become exercisable on 1/18/2008, and equal amounts of the remaining 75% shall become exercisable each month for the next three years thereafter.
Documents
Issuer
CELL THERAPEUTICS INC
CIK 0000891293
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000891293
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 9:39 PM ET
- Size
- 5.9 KB